会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • Quinolonecarboxylic Acid Compounds Having 5-Ht4 Receptor Agonistic Activity
    • 具有5-Ht4受体激活活性的喹诺酮羧酸化合物
    • US20080255113A1
    • 2008-10-16
    • US10595948
    • 2004-11-10
    • Tomoki KatoKiyoshi KawamuraMikio MoritaChikara Uchida
    • Tomoki KatoKiyoshi KawamuraMikio MoritaChikara Uchida
    • A61K31/5377C07D405/14A61K31/4709C07D401/12C07D401/14C07D413/14
    • C04B35/632C07D401/12C07D401/14C07D405/14
    • This invention provides a compound of the formula (I): wherein Het represents a heterocyclic group having one nitrogen atom, to which B binds directly, and from 4 to 7 carbon atoms, and said heterocyclic group being unsubstituted or substituted by 1 to 4 substituents independently selected from the group consisting of substituents α1; A represents an alkylene group having from 1 to 4 carbon atoms; B represents a covalent bond or an alkylene group having from 1 to 5 carbon atoms; R1 represents an isopropyl group, a n-propyl group or a cyclopentyl group; R2 represents a methyl group, a fluorine atom or a chlorine atom; R3 independently represents (i) an oxo group, a hydroxy group, an amino group, an alkylamino group or a carboxyl group; (ii) a cycloalkyl group having from 3 to 8 carbon atoms, and said cycloalkyl group being substituted by 1 to 5 substituents, or (iii) a heterocyclic group having from 3 to 8 atoms, and said heterocyclic group being unsubstituted or substituted by 1 to 5 substituents, and n is 1, 2 or 3, or a pharmaceutically acceptable salts thereof. These compounds have 5-HT4 receptor agonistic activity, and thus are useful for the treatment of gastroesophageal reflux disease, non-ulcer dyspepsia, functional dyspepsia, irritable bowel syndrome or the like in mammalian, especially humans.
    • 本发明提供式(I)化合物:其中Het表示具有一个氮原子的杂环基团,B直接与该碳原子结合,并且具有4至7个碳原子,所述杂环基团未被取代或被1至4个取代基取代 独立地选自取代基α1, A表示具有1至4个碳原子的亚烷基; B表示共价键或具有1至5个碳原子的亚烷基; R 1表示异丙基,正丙基或环戊基; R 2表示甲基,氟原子或氯原子; R 3独立地表示(i)氧代基,羟基,氨基,烷基氨基或羧基; (ii)具有3至8个碳原子的环烷基,所述环烷基被1至5个取代基取代,或(iii)具有3至8个原子的杂环基,所述杂环基未被取代或被1 至5个取代基,n为1,2或3,或其药学上可接受的盐。 这些化合物具有5-HT 4受体激动活性,因此可用于治疗哺乳动物,特别是人类的胃食管反流病,非溃疡性消化不良,功能性消化不良,肠易激综合征等。
    • 7. 发明授权
    • Microcomputer and its access speed control method
    • 微电脑及其访问速度控制方法
    • US06275747B1
    • 2001-08-14
    • US09191377
    • 1998-11-13
    • Takao WadaYuzo IshibashiKiyoshi KawamuraYoshikatsu Kuroda
    • Takao WadaYuzo IshibashiKiyoshi KawamuraYoshikatsu Kuroda
    • G05B2100
    • G06F11/00
    • A microcomputer usable for a long period of time even when disposed in a high dose radiation-exposed environment, and its access speed control method are provided. According to the microcomputer and the method, the total dose of radiation that the microcomputer receives is determined on the basis of detection signals from a radiation detecting element. Based on the determined total dose of radiation, and table data preset by tests and stored into a memory unit, a CPU controls an access speed. Moreover, the CPU, and the memory unit and a circuit interface unit that access the CPU are integrated on a single chip (ASIC) These units on the same chip are deteriorated and changed in the same direction, without fail, on exposure to radiation.
    • 即使设置在高剂量的曝光环境下也能够长时间使用的微型计算机及其存取速度控制方法。 根据微型计算机和方法,基于来自辐射检测元件的检测信号确定微机接收的辐射总剂量。 基于确定的辐射总剂量和通过测试预设的表数据并存储到存储器单元中,CPU控制访问速度。 此外,CPU,存储器单元和访问CPU的电路接口单元集成在单个芯片(ASIC)上。同一芯片上的这些单元在暴露于辐射的同时,在相同的方向上都会相同的方向劣化并改变。